Claudio J Conti

Author PubWeight™ 49.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 2003 2.12
2 Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res 2004 1.83
3 Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions. Cell Cycle 2011 1.74
4 Complexity of VEGF responses in skin carcinogenesis revealed through ex vivo assays based on a VEGF-A null mouse keratinocyte cell line. J Invest Dermatol 2008 1.42
5 The radiation-induced nackt (nkt) allele is a loss-of-function mutation of the mouse cathepsin L gene. J Immunol 2006 1.40
6 Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Mol Cell Biol 2004 1.35
7 Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells. Cancer Res 2009 1.26
8 Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation. Am J Pathol 2002 1.24
9 Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression. Neoplasia 2008 1.24
10 Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc Natl Acad Sci U S A 2005 1.19
11 Enhanced malignant tumorigenesis in Cdk4 transgenic mice. Oncogene 2004 1.15
12 Carcinogenic effects of MGP-7 and B[a]P on the hamster cheek pouch. Toxicol Pathol 2009 1.14
13 WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. Genes Chromosomes Cancer 2007 1.13
14 The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001. Mol Carcinog 2012 1.12
15 Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model. Cancer Res 2002 1.08
16 A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Cancer Res 2002 1.08
17 Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues. Oncogene 2003 1.07
18 ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol 2002 1.07
19 Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells. J Biochem Mol Biol 2005 1.05
20 Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8-expressing transgenic mice. FASEB J 2004 1.03
21 Protein kinase C and prostate carcinogenesis: targeting the cell cycle and apoptotic mechanisms. Curr Drug Targets 2004 1.01
22 Overexpression of cyclin D2 is associated with increased in vivo invasiveness of human squamous carcinoma cells. Mol Carcinog 2002 0.98
23 Inhibition of proprotein convertases: approaches to block squamous carcinoma development and progression. Mol Carcinog 2007 0.97
24 Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo. Am J Pathol 2008 0.96
25 PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth. Am J Pathol 2009 0.96
26 Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice. Carcinogenesis 2003 0.95
27 Mutation frequencies in murine keratinocytes as a function of carcinogenic status. Mol Carcinog 2004 0.92
28 Endothelial cell development, vasculogenesis, angiogenesis, and tumor neovascularization: an update. Semin Thromb Hemost 2004 0.90
29 p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas. Carcinogenesis 2002 0.90
30 Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation. Am J Pathol 2002 0.90
31 Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis. Mol Carcinog 2003 0.89
32 P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis. Breast Cancer Res Treat 2010 0.88
33 Chronic stress accelerates ultraviolet-induced cutaneous carcinogenesis. J Am Acad Dermatol 2004 0.87
34 Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromes. Am J Pathol 2010 0.87
35 Protective role of cathepsin L in mouse skin carcinogenesis. Mol Carcinog 2011 0.86
36 CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development. Am J Pathol 2008 0.84
37 SKHIN/Sprd, a new genetically defined inbred hairless mouse strain for UV-induced skin carcinogenesis studies. Exp Dermatol 2012 0.81
38 Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains. Mol Carcinog 2002 0.81
39 Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo. Exp Dermatol 2013 0.81
40 The regenerative potential of fibroblasts in a new diabetes-induced delayed humanised wound healing model. Exp Dermatol 2013 0.79
41 Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b). Mol Carcinog 2009 0.79
42 Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands. Mol Carcinog 2011 0.79
43 Developmental stage determines estrogen receptor alpha expression and non-genomic mechanisms that control IGF-1 signaling and mammary proliferation in mice. J Clin Invest 2011 0.78
44 Application of inter-simple sequence repeat PCR to mouse models: assessment of genetic alterations in carcinogenesis. Genes Chromosomes Cancer 2002 0.78
45 Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype. Leuk Res 2003 0.77
46 Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs. Mol Carcinog 2004 0.77
47 Simple duplex fecal PCR assay that allows identification of false-negative results in Helicobacter sp.-infected mice. Comp Med 2004 0.76
48 Second symposium of novel molecular targets for cancer therapy. Oncologist 2002 0.75
49 Tumor initiation by skin Ha-ras-ment. Exp Dermatol 2015 0.75
50 Immunohistochemical analysis of mTOR activity in tissues. Methods Mol Biol 2012 0.75
51 Differential susceptibility to chemically induced thymic lymphomas in SENCARB and SSIN inbred mice. Mol Carcinog 2006 0.75
52 Loss of heterozygosity analysis of mouse pulmonary adenomas induced by coal tar. Environ Mol Mutagen 2003 0.75